Subscribe To
DK / Delek US Holdings (DK) Q4 Earnings & Revenues Beat Estimates
DK News
By Zacks Investment Research
October 30, 2023
Why Delek US Holdings (DK) is Poised to Beat Earnings Estimates Again
Delek US Holdings (DK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a like more_horizontal
By Zacks Investment Research
August 18, 2023
Delek US (DK) Q2 Earnings and Revenues Surpass Estimates
Delek US (DK) plans to spend $350 million on capital expenditures for 2023, including $202 million for Refining, $81 million for Logistics, $31 millio more_horizontal
By Zacks Investment Research
August 7, 2023
Delek US Holdings (DK) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Delek US Holdings (DK) give a sense of how the business performed in the quarter ended June 2023, it could more_horizontal
By Zacks Investment Research
August 7, 2023
Delek US Holdings (DK) Q2 Earnings and Revenues Surpass Estimates
Delek US Holdings (DK) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to ear more_horizontal
By PRNewsWire
July 11, 2023
Delek US Holdings to Host Second Quarter 2023 Conference Call on August 7th
BRENTWOOD, Tenn. , July 11, 2023 /PRNewswire/ -- Delek US Holdings, Inc. (NYSE: DK) ("Delek US") today announced that the Company intends to issue a p more_horizontal
By PRNewsWire
July 11, 2023
Delek Logistics Partners, LP to Host Second Quarter 2023 Conference Call on August 7th
BRENTWOOD, Tenn. , July 11, 2023 /PRNewswire/ -- Delek Logistics Partners, LP (NYSE: DKL) ("Delek Logistics") today announced that the Partnership int more_horizontal
By Market Watch
June 20, 2023
Hit Wegovy weight-loss drug on track for $4 billion in U.S. sales despite supply constraints, analyst says
The hit Wegovy weight-loss drug is on track for sales of over $4 billion this year in the U.S. alone, despite its manufacturer Novo Nordisk struggling more_horizontal
By Zacks Investment Research
May 17, 2023
Delek US (DK) Q1 Earnings & Revenues Outpace Estimates
Delek US (DK) projects $350 million in capital expenditures for the full-year 2023. It expects to spend $202 million on Refining, $81 million on Logis more_horizontal